Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance

Newton, J. L.; Jones, D. E. J.; Henderson, E.; Kane, L.; Wilton, K.; Burt, A. D.; Day, C. P.
June 2008
Gut;Jun2008, Vol. 57 Issue 6, p807
Academic Journal
Objective: To quantify fatigue in non-alcoholic fatty liver disease (NAFLD), to determine whether perceived fatigue reflects impairment of physical function and to explore potential causes. Patients and methods: A cohort study was carried out on 156 consecutive patients with histologically proven NAFLD studied in two cohorts. Phase 1 determined the perceived fatigue experienced by NAFLD patients (assessed using the Fatigue Impact Scale (FIS)) in comparison with normal and liver disease controls, and the relationship to physical function (actigraphy). In phase 2, biological associations of fatigue in NAFLD were explored. Results: Fatigue was markedly higher in NAFLD patients than in controls (mean (SD) FIS 51(38) vs 8 (12), p<0.001). NAFLD patients showed significantly lower physical activity over 6 days (7089 (2909) mean steps/day vs 8676 (2894), p = 0.02). A significant inverse correlation was seen between FIS and physical activity (r² = 0.1, p = 0.02). Fatigue experienced by NAFLD patients was similar to that in primary biliary cirrhosis (n = 36) (FIS 64 (9) vs 61(2), p = NS). No association was seen between FIS and biochemical and histological markers of liver disease severity or insulin resistance (homeostasis model assessment (HOMA)) (r²<0.005). Significant association was seen between fatigue severity and daytime somnolence (Epworth Sleepiness Scale) (r² = 0.2, p<0.001). Conclusion: Fatigue is a significant problem in NAFLD, is similar in degree to that in primary biliary cirrhosis patients and is associated with impairment in physical function. Fatigue in NAFLD appears to be unrelated to either severity of underlying liver disease or insulin resistance, but is associated with significant daytime somnolence.


Related Articles

  • Esteatosis hepática, esteatohepatitis y marcadores de lesión hepática. Barba Evia, José Roberto // Revista Mexicana de Patologia Clinica;oct-dic2008, Vol. 55 Issue 4, p216 

    Nonalcohlic fatty liver disease affects a large proportion of the population. Is a clinicopathological entity characterized by the development of histological changes in the liver that are nearly identical to those induced by excessive alcohol intake, but in the absence of intake of this....

  • The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Qing Liu; Stig Bengmark; Shen Qu // Lipids in Health & Disease;2010, Vol. 9, p42 

    Nonalcoholic fatty liver disease is increasingly regarded as a hepatic manifestation of metabolic syndrome, and the severity of nonalcoholic fatty liver disease seems to increase in parallel with other features of metabolic syndrome. Excess lipid accumulation in the liver cells is not only a...

  • The Fatty Liver and Insulin Resistance. Yki-Järvinen, H.; Westerbacka, J. // Current Molecular Medicine;May2005, Vol. 5 Issue 3, p287 

    Obesity is not necessary to observe insulin resistance in humans since severe insulin resistance also characterizes patients lacking subcutaneous fat such as those with HAART (highlyactive antiretroviral therapy) - associated lipodystrophy. Both the obese and the lipodystrophic patients have,...

  • Pathogenesis of non-alcoholic fatty liver disease. DOWMAN, J. K.; TOMLINSON, J. W.; NEWSOME, P. N. // QJM: An International Journal of Medicine;Feb2010, Vol. 103 Issue 2, p71 

    The article discusses the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Although this disease can be experienced by all ethnic groups, there seems to have a lower prevalence rate in African Americans when compared to Hispanic and European Americans. NAFLD is often linked to features...

  • Non-alcoholic fatty liver disease and the metabolic syndrome: An update. Rector, R. Scott; Thyfault, John P.; Yongzhong Wei; Ibdah, Jamal A. // World Journal of Gastroenterology;1/14/2008, Vol. 14 Issue 2, p185 

    Sedentary lifestyle and poor dietary choices are leading to a weight gain epidemic in westernized countries, subsequently increasing the risk for developing the metabolic syndrome and nonalcoholic fatty liver disease (NAFLD). NAFLD is estimated to affect approximate 30% of the general US...

  • Diabetes and Nonalcoholic Fatty Liver Disease. Kantartzis, Konstantinos; Gastaldelli, Amalia; Magkos, Faidon; Lavoie, Jean-Marc // Experimental Diabetes Research;2012, Special section p1 

    The article discusses papers within the January 2012 issue of "Experimental Diabetes Research," including a paper on diagnosis and evaluation of nonalcoholic fatty liver disease, a paper on the role of transcription factor modifications in the pathogenesis of insulin resistance, and a paper on...

  • The blind men 'see' the elephant-the many faces of fatty liver disease. Sanal, Madhusudana Girija; Hübscher, Stefan G. // World Journal of Gastroenterology;2/14/2008, Vol. 14 Issue 6, p831 

    Nonalcoholic fatty liver disease (NAFLD) is a group of diseases with excess fat in liver in the absence of a poorly defined limit of alcohol consumption. Most common variety, a universal public health problem, is associated with insulin resistance caused by a host of genetic and epigenetic...

  • Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis. Valenti, Luca; Rametta, Raffaela; Dongiovanni, Paola; Maggioni, Marco; Fracanzani, Anna Ludovica; Zappa, Marco; Lattuada, Enzo; Roviaro, Giancarlo; Fargion, Silvia // Diabetes;May2008, Vol. 57 Issue 5, p1355 

    OBJECTIVE--Nonalcoholic fatty liver, affecting 34% of the U.S. population, is characterized by hepatic insulin resistance, which is more marked in the presence of steatohepatitis, and frequently precedes hyperglycemia. The molecular mechanisms underlying the relationship between fatty liver and...

  • Nonalcoholic fatty liver disease in asymptomatic Brazilian adolescents. Rocha, Raquel; Cotrim, Helma Pinchemel; Vieira Bitencourt, Almir Galvão; Valente Barbosa, Daniel Batista; Santos, Adméia Souza; De Moura Almeida, Alessandro; Cunha, Bruno; Guimarães, Isabel // World Journal of Gastroenterology;1/28/2009, Vol. 15 Issue 4, p473 

    AIM: To evaluate the prevalence and clinical characteristics of Nonalcoholic fatty liver disease (NAFLD) among asymptomatic Brazilian adolescents. METHODS: Transversal observational study included asymptomatic adolescents with central obesity from private and public schools in Salvador-Bahia,...


Read the Article


Sign out of this library

Other Topics